Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?

Trimetazidine (TMZ), an antianginal drug, can worsen the symptoms of movement disorders, therefore, the European Medicines Agency (EMA) recommended avoiding the use of this drug in Parkinson’s disease (PD). We investigated the impact of this recommendation on the observed trend of TMZ use in PD in H...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:eNeuro
Main Authors: Pintér, Dávid, Bereczki, Dániel, Ajtay, András, Oberfrank, Ferenc, Janszky, József, Kovács, Norbert
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2021
Assuntos:
Research Article: New Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8143021/
https://ncbi.nlm.nih.gov/pubmed/33863783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/ENEURO.0452-20.2021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados